Nektar Therapeutics Surges, Boosting Small-Cap Health ETF

Furthermore, ICU Medical rallied to anew high after raising its guidance. The company reported fourth quarter adjusted earnings-per-share of $2.98 after the bell Thursday and raised its full year 2018 EPS projections to between $6.60 and $7.30. Its fourth quarter 2017 revenue was $370.1 million, compared to $95.7 million for the same period in the prior year.

“Fourth quarter revenues, adjusted EBITDA and adjusted diluted earnings per share were slightly above our expectations,” Vivek Jain, ICU Medical’s Chief Executive Officer, said in a note.

PSCH also includes a 3.0% tilt toward ICUI.

The PowerShares S&P SmallCap Health Care Portfolio is designed to measure the performance of the health care portion of the S&P SmallCap 600 Index, which includes those engaged in the business of providing healthcare-related equipment and services 33.7%, healthcare providers & services 23.3%, pharmaceuticals 21.8%, biotech 15.0%, healthcare technologies 4.0% and life sciences tools & services 2.2%.

For more information on the healthcare segment, visit our healthcare category.